Logo-aim
Arch Iran Med. 28(1):18-23. doi: 10.34172/aim.28830

Original Article

Prognostic Impact of Right Ventricular Diastolic Dysfunction in Patients Undergoing Isolated Coronary Artery Bypass Grafting

Tahereh Davarpasand Conceptualization, Formal analysis, 1, # ORCID logo
Arezoo Zoroufian Investigation, Resources, 1, # ORCID logo
Rezvan Ahmadi Roknabadi Methodology, Project administration, 1, * ORCID logo
Mohammad Sadeq Najafi Supervision, Writing – original draft, 1, 2 ORCID logo
Zahra Karimi Data curation, 1
Soheil Mansourian Software, 1
Amirhossein Poopak Validation, 1
Roozbeh Narimani-Javid Visualization, Writing – review & editing, 1, 2

Author information:
1Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

*Corresponding Author: Rezvan Ahmadi Roknabadi, Email: rezvanahmadi1361@gmail.com
#Tahereh Davarpasand & Arezoo Zoroufian contributed equally as the co-first authors.

Abstract

Background:

Right ventricular diastolic dysfunction (RVDD) increases the volume load on the right ventricle. We aimed to evaluate the association of RVDD with perioperative outcomes in patients undergoing isolated coronary artery bypass graft surgery (CABG).

Methods:

This single-center observational study included all consecutive isolated CABG patients with a left ventricular ejection fraction (LVEF)>40% from May 2022 to May 2023 who were evaluated for RV diastolic function by transthoracic echocardiography. We divided patients into two groups, with and without RVDD, and then compared the two groups in terms of the primary outcomes of the duration of hospitalization, intensive care unit (ICU) stay, and intubation time, and the secondary outcome composed of postoperative in-hospital complications.

Results:

Our study found that 49.1% of patients suffered from RVDD, and patients with RVDD had significantly lower systolic blood pressure and were more likely to take angiotensin-converting enzyme inhibitors than those without RVDD. There was no association between RVDD and primary outcomes of hospitalization time (β=-0.01; 95% CI -0.05, 0.04; P value=0.717), ICU stay (β=0.01; 95% CI -0.18, 0.17; P value=0.984) and intubation time ([β=0.06; 95% CI -0.05, 0.17; P value=0.309). However, more postoperative complications occurred in patients with RVDD (90% vs. 85%). After adjustment for confounding factors, RVDD was not independently associated with primary and secondary outcomes.

Conclusion:

Preexisting RVDD in CABG patients with LVEF>40% increased postoperative complications but not significantly. More extensive studies are needed to evaluate RV diastolic function before cardiac surgery to identify high-risk patients and optimize their perioperative management.

Keywords: Coronary artery bypass, Prognostic factors, Right ventricular dysfunction

Copyright and License Information

© 2025 The Author(s).
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article as: Davarpasand T, Zoroufian A, Ahmadi Roknabadi R, Najafi MS, Karimi Z, Mansourian S, et al. Prognostic impact of right ventricular diastolic dysfunction in patients undergoing isolated coronary artery bypass grafting. Arch Iran Med. 2025;28(1):18-23. doi: 10.34172/aim.28830


Introduction

Coronary artery bypass graft (CABG) represents the leading cardiac surgical intervention globally, with nearly 400 000 procedures conducted annually.1 The majority of evidence concerning post-operative outcomes has predominantly focused on left ventricular (LV) function,2,3 with few studies exploring the role of the right ventricle (RV) due to the complexities associated with its geometric shape, which complicates functional assessment. The majority of studies regarding RV function emphasize systolic dysfunction, typically associated with significant left-sided heart failure. Perioperative evaluation of right ventricular filling prior to cardiac surgeries needs to be investigated thoroughly.4

Right ventricular diastolic dysfunction (RVDD) is a condition that affects the filling pressure of the RV during diastole. RVDD can be caused by various factors that increase the pressure or volume load on the RV, including LV dysfunction, valvular heart diseases, ischemic heart diseases, pulmonary embolism, and cardiomyopathies.5-8 Previous studies have highlighted preoperative RVDD and the lack of suitable target bypass arteries as independent risk factors for early mortality following CABG in individuals with markedly compromised LV function.4 Additionally, another study indicates that preoperative RVDD, female sex, and cardiopulmonary bypass serve as independent risk factors for the onset of postoperative heart failure in patients with coronary artery disease undergoing CABG.9

Given that RVDD manifests before systolic dysfunction,10 it is prudent to examine its prognostic significance in individuals with preserved left ventricular ejection fraction (LVEF). Therefore, we aimed to investigate whether RV diastolic function is associated with length of hospital stay (LOS), duration of intensive care unit (ICU) stay, intubation time and the composite of complications in patients with no clinically reduced ejection fraction (LVEF > 40) undergoing isolated CABG.


Materials and Methods

Study Population and Data Collection

This single-center, observational study was conducted at Tehran Heart Center Hospital. All consecutive isolated CABG candidate patients with no clinically reduced LVEF ( > 40%)11 from May 2022 to May 2023 were included and assessed for RV diastolic function before surgery. We excluded patients with recent acute coronary syndrome, severe tricuspid valve regurgitation, LVEF < 40%, respiratory failure due to lung disease, chronic kidney or liver disease, and malignant tumors. For each patient who met the inclusion criteria, the demographics and characteristics were collected, including age, sex, body surface area (BSA), heart failure classification according to New York Heart Association (NYHA), previous myocardial infarction (MI), hypertension (HTN), stroke history, diabetes mellitus (DM), hyperlipidemia (HLP), cigarettes smoking (CS), and history of percutaneous coronary intervention (PCI). Furthermore, intraoperative metrics were documented, encompassing cardiopulmonary bypass duration, aortic clamping duration, and graft number. Demographic, perioperative, and postoperative data were obtained through complete history taking and patients’ health records.


Evaluation of Cardiac Function

Patients with diminished diastolic RV function were identified using preoperative transthoracic echocardiography (TTE), which was acquired within a week prior to the index procedure. We used the RV focus view to evaluate the RV function by transthoracic echocardiography (Philips Affinity70C: Andover, USA: probe S5-1) and placed the Doppler probe on the RV inflow.12 To assess the RV diastolic function, we used the American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) guideline, which recommends using the tricuspid valve (TV) inflow, E/A ratio, the lateral tricuspid annular tissue Doppler velocity (e’) as parameters. All TTEs were performed by one expert echocardiographist. We also measured the tissue Doppler velocity from the lateral tricuspid annulus and obtained the values of e’, a’, e’/a’, and E/e’.13

Et/At ratio values between 0.8 and 2.1 were considered to indicate normal right ventricular diastolic function. However, diastolic RV dysfunction was determined as the Et/At ratio values less than 0.8, higher than 2.1, or Et/et’ ratio values greater than 6. An Et/At ratio value less than 0.8 indicated impaired relaxation of the RV, while values in the range of 0.8 to 2.1 and an Et/et’ ratio greater than 6 pointed to pseudonormal filling of the RV. An Et/At ratio greater than 2.1 indicated a restrictive type of RV filling.13


Outcomes

We compared the patients with and without RVDD regarding baseline characteristics. The primary outcome of this study was LOS, duration of ICU stay, and intubation time. A composite of complications, including non-fatal acute myocardial infarction, non-fatal stroke, death (cardiac and all-cause), acute renal failure, embolic events, pleural and pericardial effusion, pack cell infusion, atrial and ventricular arrhythmias, intra-aortic balloon pump (IABP), deep vein thrombosis, major gastrointestinal bleeding, DC shock, and tamponade constituted the secondary outcomes of our study.


Statistical Analysis

The R software, version 4.1.2, was used for statistical analysis. Absolute values and percentages were used to present qualitative variables. On the other hand, quantitative variables were presented as mean (standard deviation) or medians/quartiles (25th and 75th percentiles). The Mann-Whitney, independent t-tests, and chi-squared tests were used to compare the two groups. We performed logistic regression with adjustment for confounder variables to determine if RVDD is associated with the primary outcomes.


Results

Baseline Characteristics

The patients were mostly men (72.4%) with a mean age of 62.25 ± 8.76. A total of 112 (49.12%) patients had RVDD. The prevalence of RV systolic dysfunction in our study was 6%. Patients with RVDD and those without RVDD were not significantly different in age, CS, HTN, MI, NYHA, DM, stroke history, PCI history, HLP, taking beta-blockers and statins, renal failure, BSA, heart rate, and diastolic blood pressure (DBP). Men were significantly more diagnosed with RVDD (P = 0.003). Patients with RVDD used ACE inhibitors more than patients without RVDD (P = 0.035). Baseline characteristics are summarized in Table 1.


Table 1. Baseline Characteristics and Perioperative Variables Compared between Patients with and without Right Ventricular Diastolic Dysfunction
Characteristic Overall
(N=228)
Without RVDD
(n=116)
With RVDD
(n=112)
P Value*
Sex (male) 165 (72.4%) 94 (81.0%) 71 (63.4%) 0.003
Age (year) 62.25 (8.76) 61.74 (9.27) 62.77 (8.22) 0.5
Smoking 48 (21.1%) 23 (19.8%) 25 (22.3%) 0.6
Hypertension, 115 (50.4%) 52 (44.8%) 63 (56.2%) 0.085
MI history, n (%) 10 (4.4%) 4 (3.4%) 6 (5.4%) 0.5
NYHA  > 0.9
1 53 (23.2%) 26 (22.4%) 27 (24.1%)
2 147 (64.5%) 75 (64.7%) 72 (64.3%)
3 28 (12.3%) 15 (12.9%) 13 (11.6%)
Diabetes mellitus 80 (35.1%) 39 (33.6%) 41 (36.6%) 0.6
Stroke history 5 (2.2%) 3 (2.6%) 2 (1.8%)  > 0.9
PCI history 15 (6.6%) 8 (6.9%) 7 (6.2%) 0.8
Hyperlipidemia 96 (42.1%) 47 (40.5%) 49 (43.8%) 0.6
Beta-blockers 42 (18.4%) 23 (19.8%) 19 (17.0%) 0.6
Statins 98 (43.0%) 48 (41.4%) 50 (44.6%) 0.6
ACE-I 102 (44.7%) 44 (37.9%) 58 (51.8%) 0.035
Renal failure 8 (3.5%) 5 (4.3%) 3 (2.7%) 0.7
BSA 1.80 (0.20) 1.81 (0.19) 1.79 (0.21) 0.6
SBP 118.99 (9.87) 119.44 (9.64) 118.53 (10.13) 0.2
DBP 72.81 (7.97) 72.93 (8.00) 72.68 (7.97) 0.5
HR; Median (IQR) 70.00 (70.00, 80.00) 70.00 (70.00, 80.00) 70.00 (69.50, 78.50) 0.5
Echocardiographic parameters
LVEF (%) 0.7
45 49 (21%) 22 (19%) 27 (24%)
50 61 (27%) 31 (27%) 30 (27%)
55 115 (50%) 62 (53%) 53 (47%)
60 3 (1.3%) 1 (0.9%) 2 (1.8%)
Left atrium volume index, cc/m2 31 (25, 35) 31 (25, 36) 30 (26, 35)  > 0.9
E/A ratio 0.80 (0.69, 0.95) 0.81 (0.71, 1.06) 0.79 (0.69, 0.92) 0.3
E/e’, cm/s 8.80 (7.20, 10.70) 8.65 (7.20, 10.43) 8.95 (7.42, 10.90) 0.5
TAPSE, (mm) 21.00 (19.00, 23.00) 21.00 (19.75, 24.00) 20.00 (19.00, 22.25) 0.033
s’t, cm/s 11.00 (10.00, 12.00) 11.00 (10.00, 13.00) 11.00 (10.00, 12.00) 0.025
Et/At ratio 1.00 (0.81, 1.20) 1.05 (0.90, 1.26) 0.88 (0.72, 1.10)  < 0.001
e’t, cm/s 8.50 (7.00, 10.00) 10.00 (8.00, 11.00) 7.00 (6.00, 9.00)  < 0.001
e’t/a’t, ratio 0.54 (0.46, 0.68) 0.62 (0.52, 0.71) 0.50 (0.41, 0.59)  < 0.001
Et/e’t, ratio 5.46 (4.40, 6.70) 4.75 (4.25, 5.50) 6.70 (5.22, 7.73)  < 0.001
S-wave hepatic vein, cm/s 46 (36, 64) 46 (34, 65) 46 (37, 62) 0.7
D-wave hepatic vein, cm/s 33 (26, 52) 33 (26, 50) 33 (26, 54) 0.8
TRG, mmHg 24.0 (20.0, 27.0) 24.0 (20.0, 28.2) 25.0 (21.0, 27.0) 0.9
Perioperative Parameters
Graft number; median (IQR) 3.00 (3.00, 4.00) 3.00 (3.00, 4.00) 3.00 (3.00, 4.00) 0.4
Cardiopulmonary bypass duration (min) 91.06 (27.21) 92.71 (27.97) 89.36 (26.42) 0.7
Mechanical Support (day) 0.4
1 215 (94.3%) 110 (94.8%) 105 (93.8%)
2 3 (1.3%) 2 (1.7%) 1 (0.9%)
3 4 (1.8%) 3 (2.6%) 1 (0.9%)
4 2 (0.9%) 0 (0.0%) 2 (1.8%)
 ≥ 8 4 (1.6%) 1 (0.9%) 3 (2.7%)
Aortic cross-clamp time (min) 52.79 (16.97) 53.28 (16.84) 52.29 (17.17) 0.8
Inotrope infusion 68 (29.8%) 29 (33.0%) 39 (27.9%) 0.4

Abbreviations: A, Late transmitral diastolic filling; ACE-I, Angiotensin-converting enzyme inhibitor; a’t, Late diastolic tricuspid annular tissue velocity; At, Late trans tricuspid diastolic filling; e’, Early diastolic mitral annular tissue velocity; E, Early transmitral diastolic filling; e’t, Early diastolic tricuspid annular tissue velocity; Et, Early trans tricuspid diastolic filling; LVEF, Left ventricular ejection fraction; NYHA, New York Heart Association; PCI, Percutaneous coronary intervention; RVDD, Right ventricular diastolic dysfunction; s’t, Systolic tricuspid annular tissue velocity; TAPSE, Tricuspid annular plane systolic excursion; BSA, Body surface area; IABP, Intra-aortic balloon pump; TRG, Tricuspid regurgitation gradient; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HR, Heart rate.

Data is presented by n (%), Mean (SD), or median (IQR). *P < 0.05 is considered significant.

There was no significant difference between the study groups regarding perioperative parameters, i.e. the number of CABG grafts, cardiopulmonary bypass duration, aortic cross-clamp, intubation time, and inotropes infusion (Table 1).

Adverse Effects and Mortality

Patients experienced various postoperative adverse effects, including non-fatal stroke, acute renal failure, pleural effusion, pericardial effusion, tamponade, new-onset atrial fibrillation, ventricular arrhythmia, deep vein thrombosis, and DC shock. Unfortunately, 7 (3.1%) patients died postoperatively, all of whom were cardiovascular-related: 4 (3.6%) patients with RVDD and 3 (2.6%) patients without RVDD. None of the patients had non-fatal MI, thromboembolic events, or major gastrointestinal bleeding (Table 2).


Table 2. Postoperative Complications and All-Cause Mortality
Complicationsa Without RVDD
(n=116)
No. (%)
With RVDD
(n=112)
No. (%)
Composite 99 (85) 101 (90)
Non-fatal stroke 2 (1.7) 1 (0.9)
Acute renal failure 1 (0.9) 1 (0.9)
Pleural effusion 29 (25) 17 (15)
Pericardial effusion 18 (16) 14 (12)
Tamponade 2 (1.7) 0 (0)
New onset atrial fibrillation 12 (10) 13 (12)
Ventricular arrhythmia 3 (2.6) 6 (5.4)
Deep vein thrombosis 1 (0.9) 0 (0)
DC shock 0 (0) 1 (0.9)
Pack cell infusion 94 (81) 97 (87)
IABP 4 (3.4) 3 (2.7)
All-cause death 3 (2.6) 4 (3.6)
Cardiovascular death 3 (2.6) 4 (3.6)

IABP, Intra-aortic balloon pump; DC, Direct current; RVDD, Right ventricular diastolic dysfunction.

a Non-fatal MI, thromboembolic event, and major gastrointestinal bleeding were also included in the composite, but their value was zero.

Multivariate Analysis

In an adjusted regression model for crucial times as primary outcomes, RVDD had no association with hospitalization, ICU, or intubation time. Although complications were more frequently observed in RVDD patients, in the crude model and after adjusting for sex and ACE-I, our multivariate analysis showed that patients with RVDD did not have a statistically significantly higher risk of developing postoperative adverse events (Tables 3 and 4).


Table 3. Association between RVDD and Primary Outcomes
Modelsa Beta 95% CI P Value*
RVDD-Hospitalization time -0.01 -0.05, 0.04 0.717
RVDD-ICU time 0.01 -0.18, 0.17 0.984
RVDD- Intubation time 0.06 -0.05, 0.17 0.309

CI, Confidence interval; RVDD, Right ventricular diastolic dysfunction.

a Regression models have been adjusted for sex and ACE-I. * P value < 0.05 is considered significant.


Table 4. Association between Right Ventricular Diastolic Dysfunction and the Occurrence of the Composite of Complications
Modela OR 95% CI P Valueb
Crude model: RVDD 1.58 0.71, 3.63 0.3
Adjusted modela 1.49 0.66, 3.49 0.3

OR, odds ratio; CI, Confidence interval; RVDD, Right ventricular diastolic dysfunction.

a Regression adjusted for sex and ACE-I use; * P value < 0.05 is considered significant.


Discussion

This study evaluated the incidence of RVDD in isolated CABG candidates with LVEF > 40% and its effect on in-hospital complications after surgery. Including patients with LVEF > 40% excluded the confounding role of LV systolic dysfunction. Most previous studies have focused on the systolic function of the RV, which usually develops with severe left-sided heart dysfunction. Despite the evidence that RV diastolic dysfunction develops earlier than its systolic dysfunction, the diastolic function of the RV has received less attention.14-16 Therefore, this was the first study to investigate whether RV diastolic function has prognostic value in patients with preserved LV function, which is a more common scenario in CABG candidates. We found that RVDD incidence was 49.1% in the study population, but it was not associated with longer LOS in hospital and ICU, intubation time and postoperative complications such as acute renal failure, pleural and pericardial effusion, pack cell infusion, atrial and ventricular arrhythmias, IABP, and cardiovascular death.

RVDD also seems to be of prognostic importance in the perioperative settings.9,15,17 Sumin et al showed that patients with stable CAD are much more likely to have RV diastolic dysfunction than systolic dysfunction. Additionally, they discovered that the occurrence of RVDD was mostly linked to LV systolic dysfunction and older age.9 Several studies have demonstrated that in pulmonary hypertension and a diabetic model, RV diastolic dysfunction can develop before systolic failure.14,16

Diastolic dysfunction is much more prevalent in hypertensive individuals. In this regard, Zhang et al measured regional diastolic dysfunction with pulsed wave tissue Doppler in patients with hypertension and demonstrated that when the disease progressed to a more advanced stage and extended duration, the level of regional diastolic dysfunction expanded, exhibiting a trend from the right ventricular wall to the septum and LV wall.18 The wall of the RV is less thick than that of the left ventricle. The compensatory ability of right ventricular wall diastolic function in hypertensive individuals may be less effective than that of the left ventricle and interventricular septum. Therefore, a higher prevalence of hypertension and its treatment in patients with RVDD can be justified, as observed in our study, which showed that the partial diastolic function of the RV in hypertensive patients may appear earlier.

RV diastolic dysfunction is an essential prognostic factor in assessing ventricular dysfunction in heart failure.19 Left-sided heart failure is a recognized etiology of pulmonary arterial hypertension. An elevation in right ventricular afterload due to the onset of pulmonary arterial hypertension owing to persistent pulmonary venous hypertension has typically been regarded as the principal mechanism contributing to right ventricular dysfunction in patients with left-sided heart failure.20 Heart failure with preserved ejection fraction (HFpEF) is also likely to cause right heart remodeling and failure.21 Hypertrophy and extracellular fibrosis may indicate substantial right ventricular remodeling in HFpEF patients. Consequently, RVDD may indicate early right ventricular involvement in HFpEF patients or signify the shift from a compensated to a decompensated state, exacerbated by the presence of risk factors like hypertension.22

Most previous studies show RV function’s predictive value in cardiac surgery. Maslow et al showed that patients exhibiting abnormal right ventricular systolic and diastolic function and concurrent LV systolic dysfunction had less favorable outcomes following CABG.5 Similarly, Lella et al showed that in patients having isolated CABG or valve surgery, abnormal RVEF is a better indicator of long-term cardiac re-hospitalization compared to abnormal LVEF.6 Jin et al demonstrated that preoperative RVDD and the absence of appropriate target bypass arteries are independent risk factors for early mortality after CABG in individuals with significantly compromised LV function.15

Additionally, in high-risk patients having major vascular surgery, right ventricular systolic dysfunction has been independently linked to increased rates of postoperative major cardiovascular complications and prolonged hospital stays. Sumin et al showed that RVDD is much more prevalent than systolic dysfunction in individuals with stable coronary artery disease, occurring in 46% and 7.5% of cases, respectively. We reported that 49.1% of patients were diagnosed with RVDD, and the prevalence of RV systolic dysfunction in our study was 6%. The occurrence of RVDD was mostly linked to advanced age and LV systolic dysfunction but not to coronary artery lesions.9 Conversely, in our study, RVDD was not associated with age, LV systolic dysfunction, or coronary artery lesions.

The present study had some limitations. The main limitation of our study is that we included a small sample size from a single center and did not evaluate the long-term outcomes of the patients, such as survival and re-hospitalization. Therefore, we cannot determine whether RVDD impacts the long-term prognosis of CABG patients. Furthermore, the characterization of RV function relied on standard parameters of RV systolic and diastolic function, disregarding advanced techniques such as speckle-tracking RV assessment, three-dimensional RV echocardiography, and CMR. Moreover, we considered a complex composite of complications as the secondary outcomes; these might explain the slightly different results from the rest of the literature in our work. While we adjusted for several known confounders, residual confounding due to unmeasured variables may still be present. These factors should be considered when interpreting the results, and further studies are warranted to validate these findings in broader and more diverse populations. We recommend further multi-centric evaluations with a larger sample size to better understand the effects of RVDD on CABG postoperative outcomes.


Conclusion

Although patients with RVDD and LVEF > 40% suffered more composite postoperative complications after CABG, the association was statistically insignificant; therefore, more extensive studies are required to identify the predictive role of RV diastolic dysfunction in postoperative outcomes.


Competing Interests

None declared.

Consent for Publication

Not applicable.

Data Availability Statement

The dataset of the present study is available upon reasonable request from the corresponding author.

Ethical Approval

The study was carried out in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Tehran Heart Center (Ethic code: IR.TUMS.THC.REC.1401.029). All participant provided informed consent prior to their involvement in the investigation.

Funding

None.


References

  1. Alexander JH, Smith PK. Coronary-artery bypass grafting. N Engl J Med 2016; 375(10):e22. doi: 10.1056/NEJMc1608042 [Crossref] [ Google Scholar]
  2. Appoo J, Norris C, Merali S, Graham MM, Koshal A, Knudtson ML. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation 2004; 110(11 Suppl 1):II13-7. doi: 10.1161/01.CIR.0000138345.69540.ed [Crossref] [ Google Scholar]
  3. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg 1998; 66(5):1632-9. doi: 10.1016/s0003-4975(98)00773-5 [Crossref] [ Google Scholar]
  4. Jin Y, Wang H, Wang Z, Jiang H, Tao D, Wu H. The evaluation of preoperative right ventricular diastolic dysfunction on coronary artery disease patients with left ventricular dysfunction. Echocardiography 2014; 31(10):1259-64. doi: 10.1111/echo.12652 [Crossref] [ Google Scholar]
  5. Maslow AD, Regan MM, Panzica P, Heindel S, Mashikian J, Comunale ME. Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction. Anesth Analg 2002; 95(6):1507-18. doi: 10.1097/00000539-200212000-00009 [Crossref] [ Google Scholar]
  6. Lella LK, Sales VL, Goldsmith Y, Chan J, Iskandir M, Gulkarov I. Reduced right ventricular function predicts long-term cardiac re-hospitalization after cardiac surgery. PLoS One 2015; 10(7):e0132808. doi: 10.1371/journal.pone.0132808 [Crossref] [ Google Scholar]
  7. Couperus LE, Delgado V, Palmen M, van Vessem ME, Braun J, Fiocco M. Right ventricular dysfunction affects survival after surgical left ventricular restoration. J Thorac Cardiovasc Surg 2017; 153(4):845-52. doi: 10.1016/j.jtcvs.2016.09.038 [Crossref] [ Google Scholar]
  8. Peyrou J, Chauvel C, Pathak A, Simon M, Dehant P, Abergel E. Preoperative right ventricular dysfunction is a strong predictor of 3 years survival after cardiac surgery. Clin Res Cardiol 2017; 106(9):734-42. doi: 10.1007/s00392-017-1117-y [Crossref] [ Google Scholar]
  9. Sumin AN, Korok EV, Sergeeva TJ. Preexisting right ventricular diastolic dysfunction and postoperative cardiac complications in patients undergoing nonemergency coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2021; 35(3):799-806. doi: 10.1053/j.jvca.2020.09.100 [Crossref] [ Google Scholar]
  10. Murch SD, La Gerche A, Roberts TJ, Prior DL, MacIsaac AI, Burns AT. Abnormal right ventricular relaxation in pulmonary hypertension. Pulm Circ 2015; 5(2):370-5. doi: 10.1086/681268 [Crossref] [ Google Scholar]
  11. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022; 24(1):4-131. doi: 10.1002/ejhf.2333 [Crossref] [ Google Scholar]
  12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16(3):233-70. doi: 10.1093/ehjci/jev014 [Crossref] [ Google Scholar]
  13. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23(7):685-713. doi: 10.1016/j.echo.2010.05.010 [Crossref] [ Google Scholar]
  14. Miao Y, Zhang W, Zhongi Y, Ma X. Diastolic function of the right ventricle is impaired in experimental type 2 diabetic rat models. Turk J Med Sci 2014; 44(3):448-53. doi: 10.3906/sag-1212-12 [Crossref] [ Google Scholar]
  15. Jin Y, Wang H, Wang Z, Jiang H, Tao D, Wu H. The evaluation of preoperative right ventricular diastolic dysfunction on coronary artery disease patients with left ventricular dysfunction. Echocardiography 2014; 31(10):1259-64. doi: 10.1111/echo.12652 [Crossref] [ Google Scholar]
  16. Murch SD, La Gerche A, Roberts TJ, Prior DL, MacIsaac AI, Burns AT. Abnormal right ventricular relaxation in pulmonary hypertension. Pulm Circ 2015; 5(2):370-5. doi: 10.1086/681268 [Crossref] [ Google Scholar]
  17. Kato TS, Jiang J, Schulze PC, Jorde U, Uriel N, Kitada S. Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. JACC Heart Fail 2013; 1(3):216-22. doi: 10.1016/j.jchf.2013.02.005 [Crossref] [ Google Scholar]
  18. Zhang X, Wu CE, Ye P, Sheng L, Luo L. Right ventricle may be involved in regional diastolic dysfunction earliest in primary hypertension patients. J Cell Biochem 2019; 120(10):18088-93. doi: 10.1002/jcb.29112 [Crossref] [ Google Scholar]
  19. Riggs TW. Abnormal right ventricular filling in patients with dilated cardiomyopathy. Pediatr Cardiol 1993; 14(1):1-4. doi: 10.1007/bf00794835 [Crossref] [ Google Scholar]
  20. Morris DA, Gailani M, Vaz Pérez A, Blaschke F, Dietz R, Haverkamp W. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr 2011; 24(8):886-97. doi: 10.1016/j.echo.2011.04.005 [Crossref] [ Google Scholar]
  21. Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res 2019; 124(11):1598-617. doi: 10.1161/circresaha.119.313572 [Crossref] [ Google Scholar]
  22. Jung YH, Ren X, Suffredini G, Dodd OJ, Gao WD. Right ventricular diastolic dysfunction and failure: a review. Heart Fail Rev 2022; 27(4):1077-90. doi: 10.1007/s10741-021-10123-8 [Crossref] [ Google Scholar]
Submitted: 20 Jan 2024
Accepted: 02 Dec 2024
First published online: 01 Jan 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 391
PDF Download: 343
Full Text View: 46